We have located links that may give you full text access.
Journal Article
Review
Sugar-sweetened beverages consumption and the risk of depression: A meta-analysis of observational studies.
Journal of Affective Disorders 2018 November 7
BACKGROUND: It remains inconsistent whether sugar-sweetened beverages (SSBs) consumption increases the risk of depression. Thus, we carried out a meta-analysis to evaluate the association between SSBs consumption and the risk of depression.
METHODS: PubMed and Web of Science were searched for relevant articles published up to June 2018. Pooled relative risks (RRs) and 95% confidence intervals (CIs) were calculated by the fixed-effects model or random effect model based on heterogeneity test.
RESULTS: 10 observational studies involving 37,131 depression cases among 365,289 participants were included. The combined risk of depression for the highest versus lowest consumption of SSBs was 1.31 (95% CI 1.24-1.39). The findings were consistent in the cross-sectional studies (RR = 1.38; 95% CI 1.26-1.52) as well as in the cohort studies (RR = 1.30; 95% CI 1.19-1.41) A nonlinear dose-response relationship was found (Pnonlinearity = 0.0103) for depression risk and SSBs consumption. Compared with SSBs nondrinkers, those who drank the equivalent of 2 cups/day of cola might increase the risk of depression by 5% (RR = 1.05; 95% CI 1.01-1.09). And the equivalent of 3cans/day of cola might have approximately 25% higher risk of depression.
LIMITATIONS: 10 studies were included in this meta-analysis, of which only 4 were cohort studies, and more cohort studies need to be performed in the future.
CONCLUSIONS: This meta-analysis indicates that SSBs consumption might be associated with a modestly higher risk of depression. The results need to be further confirmed in the future.
METHODS: PubMed and Web of Science were searched for relevant articles published up to June 2018. Pooled relative risks (RRs) and 95% confidence intervals (CIs) were calculated by the fixed-effects model or random effect model based on heterogeneity test.
RESULTS: 10 observational studies involving 37,131 depression cases among 365,289 participants were included. The combined risk of depression for the highest versus lowest consumption of SSBs was 1.31 (95% CI 1.24-1.39). The findings were consistent in the cross-sectional studies (RR = 1.38; 95% CI 1.26-1.52) as well as in the cohort studies (RR = 1.30; 95% CI 1.19-1.41) A nonlinear dose-response relationship was found (Pnonlinearity = 0.0103) for depression risk and SSBs consumption. Compared with SSBs nondrinkers, those who drank the equivalent of 2 cups/day of cola might increase the risk of depression by 5% (RR = 1.05; 95% CI 1.01-1.09). And the equivalent of 3cans/day of cola might have approximately 25% higher risk of depression.
LIMITATIONS: 10 studies were included in this meta-analysis, of which only 4 were cohort studies, and more cohort studies need to be performed in the future.
CONCLUSIONS: This meta-analysis indicates that SSBs consumption might be associated with a modestly higher risk of depression. The results need to be further confirmed in the future.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Ventilator Waveforms May Give Clues to Expiratory Muscle Activity.American Journal of Respiratory and Critical Care Medicine 2024 April 25
Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use.Pharmaceuticals 2024 March 27
Systemic lupus erythematosus.Lancet 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app